Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system

Nature Neuroscience

Volumn 7, Issue 2, 2004, Pages 153-159

  Cruz, Hans G ^a   Ivanova, Tatiana ^a   Lunn, Marie Louise ^b   Stoffel, Markus ^c   Slesinger, Paul A ^b   Lüscher, Christian ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; BACLOFEN; DOPAMINE; INWARDLY RECTIFYING POTASSIUM CHANNEL;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL TYPE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR3; LIMBIC CORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REWARD; VENTRAL TEGMENTUM;

ANIMALS; BACLOFEN; DOPAMINE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GABA AGONISTS; HUMANS; HYDROXYBUTYRATES; MICE; NEURONS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RECEPTORS, GABA-B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VENTRAL TEGMENTAL AREA;

EID: 1642499473     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1181     Document Type: Article

References (50)

1. Robbins, T.W. & Everitt, B.J. Drug addiction: bad habits add up. Nature 398, 567-570(1999).
2. B agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 37, 478-484 (2002).
3. B receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 65, 209-220 (2002).
4. Martellotta, M.C., Cossu, G., Fattore, L., Gessa, G.L. & Fratta, W. Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice. Eur. Neuropsychopharmacol. 8, 293-296 (1998).
5. Nicholson, K.L. & Balster, R.L. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 63, 1-22 (2001).
6. Johnson, S.W. & North, R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488 (1992).
7. McFarland, K. & Kalivas, P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 21, 8655-8663 (2001).
8. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19, 687-695 (1997).
9. + channels. Trends Neurosci. 24, 339-346 (2001).
10. +-channel proteins. Nature 374, 135-141 (1995).
11. + channels in the brain. FEBS Lett. 353, 37-42 (1994).
12. + channel: expression cloning and molecular properties. Proc. Natl. Acad. Sci. USA 90, 10235-10239 (1993).
13. Kubo, Y., Reuveny, E., Slesinger, P.A., Jan, Y.N. & Jan, L.Y. Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 364, 802-806 (1993).
14. Wickman, K., Pu, W.T. & Clapham, D.E. Structural characterization of the mouse Girk genes. Gene 284, 241-250 (2002).
15. + channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J. Neurosci. 16, 7137-7150 (1996).
16. + channels containing GIRK3. J. Membr. Biol. 169, 123-129 (1999).
17. Schoots, O. et al. Co-expression of human Kir3 subunits can yield channels with different functional properties. Cell Signal 11, 871-883 (1999).
18. + channels. Neuron 16, 321-331 (1996).
19. + channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J. Neurosci. 19, 1006-1017 (1999).
20. + (GIRK) channels composed of GIRK2 and GIRK3. J. Biol. Chem. 275, 36211-36216 (2000).
21. + channels. J. Biol. Chem. 270, 28660-28667 (1995).
22. Wei, J. et al. Characterization of murine Girk2 transcript isoforms: structure and differential expression. Genomics 51, 379-390 (1998).
23. B receptors. Neuropharmacol. 38, 1667-1673 (1999).
24. B receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J. Pharm. Exp. Ther. 287, 261-265 (1998).
25. B receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J. Pharm. Exp. Ther. 305, 668-674 (2003).
26. B receptor. Nature 396, 679-682 (1998).
27. B-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683-687 (1998).
28. B1. Neuron 31, 47-58 (2001).
29. B receptor isoforms GBR1a and GBR1b, appear to be associated with pre- and post-synaptic elements respectively in rat and human cerebellum. Br. J. Pharmacol. 126, 1387-1392 (1999).
30. B receptors expressed in mammalian cells. Br. J. Pharmacol. 128, 1370-1374 (1999).
31. BR1 receptor. Eur. J. Neurosci. 11, 2874-2882 (1999).
32. + channel mRNAs are differentially expressed in the adult rat brain. J. Neurosci. 16, 3559-3570 (1996).
33. + channel subunit GIRK4. J. Neurosci. 20, 5608-5615 (2000).
34. Torrecilla, M. et al. G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. J. Neurosci. 22, 4328-4334 (2002).
35. Ma, D. et al. Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 33, 715-729 (2002).
36. Jeong, S.W. & Ikeda, S.R. Endogenous regulator of G-protein signaling proteins modify N-type calcium channel modulation in rat sympathetic neurons. J. Neurosci. 20, 4489-4496 (2000).
37. Huang, C.L., Feng, S. & Hilgemann, D.W. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 391, 803-806 (1998).
38. Logothetis, D.E., Kurachi, Y., Galper, J., Neer, E.J. & Clapham, D.E. The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325, 321-326 (1987).
39. Reuveny, E. et al. Activation of the cloned muscarinic potassium channel by G protein beta gamma subunits. Nature 370, 143-146 (1994).
40. Johnson, S.W. & North, R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. (Lond.) 450, 455-468 (1992).
41. B receptors originate from discrete afferent neurons. Neurosci. Lett. 134, 207-211 (1992).
42. Matindale - The Complete Drug Reference p. 2496 (The Pharmaceutical Press, 2002).
43. Kalivas, P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 18, 75-113 (1993).
44. Kalivas, P.W., Duffy, P. & Eberhardt, H. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J. Pharm. Exp. Ther. 253, 858-866 (1990).
45. Feigenbaum, J.J. & Howard, S.G. Does gamma-hydroxybutyrate inhibit or stimulate central DA release? Int. J. Neurosci. 88, 53-69 (1996).
46. Gallimberti, L. et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2, 787-789 (1989).
47. Snead, O.C. III. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J. Neurochem. 75, 1986-1996 (2000).
48. Andriamampandry, C. et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J. 17, 1691-1693 (2003).
49. -/- mice. Brit. J. Pharmacol. 140, 315-322 (2003).
50. B(1) deficient mice. Eur. J. Neurosci. 18, 2722-2730 (2003).